{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T07:39:00Z","timestamp":1793777940436,"version":"4.6.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T00:00:00Z","timestamp":1626825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T00:00:00Z","timestamp":1626825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s40257-021-00623-6","type":"journal-article","created":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T06:04:02Z","timestamp":1626847442000},"page":"837-851","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Steroid Phobia: A Review of Prevalence, Risk Factors, and Interventions"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0014-0452","authenticated-orcid":false,"given":"Marissa","family":"Contento","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Cline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,21]]},"reference":[{"key":"623_CR1","doi-asserted-by":"crossref","unstructured":"Cutler RL, Fernandez-Llimos F, Frommer M, Benrimoj C, Garcia-Cardenas V. Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 2018;8(1):e016982.","DOI":"10.1136\/bmjopen-2017-016982"},{"issue":"2","key":"623_CR2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jaad.2006.05.073","volume":"56","author":"J Krejci-Manwaring","year":"2007","unstructured":"Krejci-Manwaring J, Tusa MG, Carroll C, Camacho F, Kaur M, Carr D, et al. Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis. J Am Acad Dermatol. 2007;56(2):211\u20136.","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"623_CR3","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1001\/jamadermatol.2017.2437","volume":"153","author":"AW Li","year":"2017","unstructured":"Li AW, Yin ES, Antaya RJ. Topical corticosteroid phobia in atopic dermatitis: a systematic review. JAMA Dermatol. 2017;153(10):1036\u201342.","journal-title":"JAMA Dermatol"},{"issue":"3","key":"623_CR4","doi-asserted-by":"publisher","first-page":"e172","DOI":"10.1111\/jdv.13961","volume":"31","author":"F Gonzales","year":"2017","unstructured":"Gonzales F, Ramdane N, Delebarre-Sauvage C, Modiano P, Duhamel A, Lasek A. Monitoring of topical corticosteroid phobia in a population of parents with children with atopic dermatitis using the TOPICOP. J Eur Acad Dermatol Venereol. 2017;31(3):e172\u20134.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"623_CR5","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1159\/000446068","volume":"232","author":"SM M\u00fcller","year":"2016","unstructured":"M\u00fcller SM, Tomaschett D, Euler S, Vogt DR, Herzog L, Itin P. Topical corticosteroid concerns in dermatological outpatients: a cross-sectional and interventional study. Dermatology. 2016;232(4):444\u201352.","journal-title":"Dermatology"},{"issue":"2","key":"623_CR6","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1080\/09546634.2016.1201189","volume":"28","author":"SM Mueller","year":"2017","unstructured":"Mueller SM, Itin P, Vogt DR, Walter M, Lang U, Griffin LL, et al. Assessment of \u201ccorticophobia\u201d as an indicator of non-adherence to topical corticosteroids: a pilot study. J Dermatolog Treat. 2017;28(2):104\u201311.","journal-title":"J Dermatolog Treat"},{"issue":"4","key":"623_CR7","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1111\/j.1365-2133.2011.10449.x","volume":"165","author":"H Aubert-Wastiaux","year":"2011","unstructured":"Aubert-Wastiaux H, Moret L, Le Rhun A, Fontenoy AM, Nguyen JM, Leux C, et al. Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency. Br J Dermatol. 2011;165(4):808\u201314.","journal-title":"Br J Dermatol"},{"issue":"5","key":"623_CR8","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1046\/j.1365-2133.2000.03473.x","volume":"142","author":"CR Charman","year":"2000","unstructured":"Charman CR, Morris AD, Williams HC. Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol. 2000;142(5):931\u20136.","journal-title":"Br J Dermatol"},{"key":"623_CR9","doi-asserted-by":"crossref","unstructured":"Werfel T, Schwerk N, Hansen G, Kapp A. The diagnosis and graded therapy of atopic dermatitis. Dtsch Arztebl Int. 2014;111(29-30):509\u201320.","DOI":"10.3238\/arztebl.2014.0509"},{"issue":"3","key":"623_CR10","first-page":"250","volume":"16","author":"SP McGregor","year":"2017","unstructured":"McGregor SP, Farhangian ME, Huang KE, Feldman SR. Treatment of atopic dermatitis in the United States: analysis of data from the National Ambulatory Medical Care Survey. J Drugs Dermatol. 2017;16(3):250\u20135.","journal-title":"J Drugs Dermatol"},{"issue":"3","key":"623_CR11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.11622\/smedj.2019110","volume":"61","author":"E Choi","year":"2020","unstructured":"Choi E, Chandran NS, Tan C. Corticosteroid phobia: a questionnaire study using TOPICOP score. Singapore Med J. 2020;61(3):149\u201353.","journal-title":"Singapore Med J"},{"key":"623_CR12","doi-asserted-by":"crossref","unstructured":"Carroll CL, Balkrishnan R, Feldman SR, Fleischer AB, Manuel JC. The burden of atopic dermatitis: impact on the patient, family, and society. Pediatr Dermatol. 2005;22(3):192\u20139.","DOI":"10.1111\/j.1525-1470.2005.22303.x"},{"issue":"11","key":"623_CR13","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1080\/08035250600612298","volume":"95","author":"KL Hon","year":"2006","unstructured":"Hon KL, Kam WY, Leung TF, Lam MC, Wong KY, Lee KC, et al. Steroid fears in children with eczema. Acta Paediatr. 2006;95(11):1451\u20135.","journal-title":"Acta Paediatr"},{"issue":"5","key":"623_CR14","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3109\/09546634.2015.1025030","volume":"26","author":"KL Hon","year":"2015","unstructured":"Hon KL, Tsang YC, Pong NH, Luk DC, Lee VW, Woo WM, et al. Correlations among steroid fear, acceptability, usage frequency, quality of life and disease severity in childhood eczema. J Dermatolog Treat. 2015;26(5):418\u201325.","journal-title":"J Dermatolog Treat"},{"issue":"7","key":"623_CR15","doi-asserted-by":"publisher","first-page":"467","DOI":"10.5694\/mja12.10802","volume":"199","author":"SD Smith","year":"2013","unstructured":"Smith SD, Stephens AM, Werren JC, Fischer GO. Treatment failure in atopic dermatitis as a result of parental health belief. Med J Aust. 2013;199(7):467\u20139.","journal-title":"Med J Aust"},{"key":"623_CR16","doi-asserted-by":"crossref","unstructured":"Moret L, Anthoine E, Aubert-Wastiaux H, Le Rhun A, Leux C, Mazereeuw-Hautier J, et al. TOPICOP\u00a9: a new scale evaluating topical corticosteroid phobia among atopic dermatitis outpatients and their parents. PLoS One. 2013;8(10):e76493.","DOI":"10.1371\/journal.pone.0076493"},{"issue":"11","key":"623_CR17","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1111\/all.13189","volume":"72","author":"JF Stalder","year":"2017","unstructured":"Stalder JF, Aubert H, Anthoine E, Futamura M, Marcoux D, Morren MA, et al. Topical corticosteroid phobia in atopic dermatitis: International feasibility study of the TOPICOP score. Allergy. 2017;72(11):1713\u20139.","journal-title":"Allergy"},{"issue":"3","key":"623_CR18","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1080\/09546634.2018.1508817","volume":"30","author":"SY Song","year":"2019","unstructured":"Song SY, Jung SY, Kim E. Steroid phobia among general users of topical steroids: a cross-sectional nationwide survey. J Dermatolog Treat. 2019;30(3):245\u201350.","journal-title":"J Dermatolog Treat"},{"issue":"4","key":"623_CR19","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/pde.13527","volume":"35","author":"Y Li","year":"2018","unstructured":"Li Y, Han T, Li W, Guo X, Zheng L. Awareness of and phobias about topical corticosteroids in parents of infants with eczema in Hangzhou, China. Pediatr Dermatol. 2018;35(4):463\u20137.","journal-title":"Pediatr Dermatol"},{"key":"623_CR20","doi-asserted-by":"crossref","unstructured":"Kojima R, Fujiwara T, Matsuda A, Narita M, Matsubara O, Nonoyama S, et al. Factors associated with steroid phobia in caregivers of children with atopic dermatitis. Pediatr Dermatol. 2013;30(1):29\u201335.","DOI":"10.1111\/j.1525-1470.2012.01808.x"},{"issue":"1","key":"623_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1365-4632.2004.02345.x","volume":"45","author":"M Barbeau","year":"2006","unstructured":"Barbeau M, Bpharm HL. Burden of atopic dermatitis in Canada. Int J Dermatol. 2006;45(1):31\u20136.","journal-title":"Int J Dermatol"},{"issue":"2","key":"623_CR22","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s40257-017-0318-5","volume":"19","author":"S Moawad","year":"2018","unstructured":"Moawad S, Mah\u00e9 E, Aubert-Wastiaux H, Phan A, Maruani A, Chiaverini C, et al. Topical corticosteroid concerns among parents of children with psoriasis versus atopic dermatitis: a French multicenter cross-sectional study. Am J Clin Dermatol. 2018;19(2):261\u20135.","journal-title":"Am J Clin Dermatol"},{"issue":"5","key":"623_CR23","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1080\/09546634.2016.1255307","volume":"28","author":"SM Mueller","year":"2017","unstructured":"Mueller SM, Tomaschett D, Vogt DR, Itin P, Cozzio A, Surber C. Topical corticosteroid concerns from the clinicians\u2019 perspective. J Dermatolog Treat. 2017;28(5):464\u20138.","journal-title":"J Dermatolog Treat"},{"issue":"2","key":"623_CR24","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2340\/00015555-2157","volume":"96","author":"D Raffin","year":"2016","unstructured":"Raffin D, Giraudeau B, Samimi M, Machet L, Pourrat X, Maruani A. Corticosteroid phobia among pharmacists regarding atopic dermatitis in children: a national French survey. Acta Derm Venereol. 2016;96(2):177\u201380.","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"623_CR25","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/pai.13394","volume":"32","author":"T Gerner","year":"2021","unstructured":"Gerner T, Haugaard JH, Vestergaard C, Deleuran M, Jemec GB, Mortz CG, et al. Healthcare utilization in Danish children with atopic dermatitis and parental topical corticosteroid phobia. Pediatr Allergy Immunol. 2021;32(2):331\u201341.","journal-title":"Pediatr Allergy Immunol"},{"issue":"11","key":"623_CR26","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.2340\/00015555-3220","volume":"99","author":"L Lambrechts","year":"2019","unstructured":"Lambrechts L, Gilissen L, Morren MA. Topical corticosteroid phobia among healthcare professionals using the TOPICOP score. Acta Derm Venereol. 2019;99(11):1004\u20138.","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"623_CR27","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/pde.13698","volume":"36","author":"B Bos","year":"2019","unstructured":"Bos B, Antonescu I, Osinga H, Veenje S, de Jong K, de Vries TW. Corticosteroid phobia (corticophobia) in parents of young children with atopic dermatitis and their health care providers. Pediatr Dermatol. 2019;36(1):100\u20134.","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"623_CR28","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/pde.13784","volume":"36","author":"M Saito-Abe","year":"2019","unstructured":"Saito-Abe M, Futamura M, Yamamoto-Hanada K, Yang L, Suzuki K, Ohya Y. Topical corticosteroid phobia among caretakers of children with atopic dermatitis: a cross-sectional study using TOPICOP in Japan. Pediatr Dermatol. 2019;36(3):311\u20136.","journal-title":"Pediatr Dermatol"},{"key":"623_CR29","doi-asserted-by":"crossref","unstructured":"Salas-Walinsundin WM, Wong V, Chong JH, Koh MJA. Steroid phobia in children with atopic dermatitis and their caregivers in Singapore. Dermatol Ther. 2020;33(3):e13452.","DOI":"10.1111\/dth.13452"},{"issue":"5","key":"623_CR30","doi-asserted-by":"publisher","first-page":"499","DOI":"10.5021\/ad.2015.27.5.499","volume":"27","author":"JY Lee","year":"2015","unstructured":"Lee JY, Her Y, Kim CW, Kim SS. Topical corticosteroid phobia among parents of children with atopic eczema in Korea. Ann Dermatol. 2015;27(5):499\u2013506.","journal-title":"Ann Dermatol"},{"issue":"5","key":"623_CR31","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1046\/j.1365-2230.2003.01357.x","volume":"28","author":"PE Beattie","year":"2003","unstructured":"Beattie PE, Lewis-Jones MS. Parental knowledge of topical therapies in the treatment of childhood atopic dermatitis. Clin Exp Dermatol. 2003;28(5):549\u201353.","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"623_CR32","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1111\/bjd.15130","volume":"176","author":"EJ Teale","year":"2017","unstructured":"Teale EJ, Muller I, Santer M. Carers\u2019 views of topical corticosteroid use in childhood eczema: a qualitative study of online discussion forums. Br J Dermatol. 2017;176(6):1500\u20137.","journal-title":"Br J Dermatol"},{"issue":"3","key":"623_CR33","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s11096-019-00827-1","volume":"41","author":"ES Koster","year":"2019","unstructured":"Koster ES, Philbert D, Wagelaar KR, Galle S, Bouvy ML. Optimizing pharmaceutical care for pediatric patients with dermatitis: perspectives of parents and pharmacy staff. Int J Clin Pharm. 2019;41(3):711\u20138.","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"623_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13052-017-0330-7","volume":"43","author":"M El Hachem","year":"2017","unstructured":"El Hachem M, Gesualdo F, Ricci G, Diociaiuti A, Giraldi L, Ametrano O, et al. Topical corticosteroid phobia in parents of pediatric patients with atopic dermatitis: a multicentre survey. Ital J Pediatr. 2017;43(1):22.","journal-title":"Ital J Pediatr"},{"issue":"3","key":"623_CR35","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/j.1440-0960.2010.00636.x","volume":"51","author":"SD Smith","year":"2010","unstructured":"Smith SD, Hong E, Fearns S, Blaszczynski A, Fischer G. Corticosteroid phobia and other confounders in the treatment of childhood atopic dermatitis explored using parent focus groups. Aust J Dermatol. 2010;51(3):168\u201374.","journal-title":"Aust J Dermatol"},{"issue":"276","key":"623_CR36","first-page":"243","volume":"46","author":"A Jaworek","year":"2019","unstructured":"Jaworek A, Szafraniec K, Pastuszczak M, Zalewski A, Wojas-Pelc A. The knowledge of issues associated with topical corticosteroids using in patients with atopic dermatitis. Pol Merkur Lekarski. 2019;46(276):243\u20137.","journal-title":"Pol Merkur Lekarski"},{"issue":"1","key":"623_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/1203475419871050","volume":"24","author":"MC Johnson","year":"2020","unstructured":"Johnson MC, Pona A, Adler-Neal AL, Kesty C, Cline A, Feldman SR. Assessing the effect of clinical trial evidence and anecdote on caregivers\u2019 willingness to use corticosteroids: a randomized controlled trial [formula: see text]. J Cutan Med Surg. 2020;24(1):17\u201322.","journal-title":"J Cutan Med Surg"},{"key":"623_CR38","unstructured":"Huynh R, HH W, DCW A, MPHS T. Adherence to topical corticosteroids and moisturisers in adults with endogenous eczema in Singapore. Hong Kong J Dermatol Venereol. 2015;23(4):161\u201374."},{"issue":"7","key":"623_CR39","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1080\/09546634.2017.1306017","volume":"28","author":"SD Smith","year":"2017","unstructured":"Smith SD, Farrugia LL, Harris V, Lee A, Carter SR, Blaszczynski A, et al. Evaluation of the influence of family and friends, and the Internet on patient perceptions of long-term topical corticosteroid use. J Dermatolog Treat. 2017;28(7):642\u20136.","journal-title":"J Dermatolog Treat"},{"issue":"6","key":"623_CR40","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.jaad.2020.02.079","volume":"83","author":"E Choi","year":"2020","unstructured":"Choi E, Tan KW, Tang F, Tan C, Chandran NS. Efficacy of targeted education in reducing topical steroid phobia: a randomized clinical trial. J Am Acad Dermatol. 2020;83(6):1681\u20137.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"623_CR41","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/bjd.17929","volume":"181","author":"P Maghen","year":"2019","unstructured":"Maghen P, Unrue EL, Oussedik E, Cline A, Cardwell LA, Feldman SR. Regardless of how risks are framed, patients seem hesitant to use topical steroids for atopic dermatitis. Br J Dermatol. 2019;181(4):842\u20134.","journal-title":"Br J Dermatol"},{"issue":"1","key":"623_CR42","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12895-020-00119-6","volume":"20","author":"M Lundborg","year":"2020","unstructured":"Lundborg M, Holm JH, Sandvik L, Lossius AH, Rehbinder EM, Sitek JC, Berents TL. Multidisciplinary educational programme for caregivers of children with atopic dermatitis in South East Norway: an observational study. BMC Dermatol. 2020;20(1):20.","journal-title":"BMC Dermatol"},{"issue":"12","key":"623_CR43","doi-asserted-by":"publisher","first-page":"e846","DOI":"10.1111\/jdv.16739","volume":"34","author":"H Dufresne","year":"2020","unstructured":"Dufresne H, Bataille P, Bellon N, Compain S, Deladri\u00e8re E, Bekel L, et al. Risk factors for corticophobia in atopic dermatitis. J Eur Acad Dermatol Venereol. 2020;34(12):e846\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"623_CR44","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1111\/j.1398-9995.2008.01866.x","volume":"63","author":"T Zuberbier","year":"2008","unstructured":"Zuberbier T, Maurer M, Augustin M. Use of topical steroids is largely restricted by irrational emotional concerns in both patients and physicians. Allergy. 2008;63(11):1560\u20131.","journal-title":"Allergy"},{"issue":"6","key":"623_CR45","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/j.1365-2230.1991.tb01232.x","volume":"16","author":"CC Long","year":"1991","unstructured":"Long CC, Finlay AY. The finger-tip unit: a new practical measure. Clin Exp Dermatol. 1991;16(6):444\u20137.","journal-title":"Clin Exp Dermatol"},{"key":"623_CR46","doi-asserted-by":"crossref","unstructured":"Ponnambath N, Pynn E. How to reassure patients with topical steroid phobia. 2014;25(5):21\u20133.","DOI":"10.1002\/psb.1172"},{"issue":"1","key":"623_CR47","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/jdv.12670","volume":"30","author":"HE Gustavsen","year":"2016","unstructured":"Gustavsen HE, Gjersvik P. Topical corticosteroid phobia among parents of children with atopic dermatitis in a semirural area of Norway. J Eur Acad Dermatol Venereol. 2016;30(1):168.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"623_CR48","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1080\/00016357.2020.1739329","volume":"78","author":"AI Lorenzo-Pouso","year":"2020","unstructured":"Lorenzo-Pouso AI, Rodr\u00edguez-Gonz\u00e1lez F, Blanco-Carri\u00f3n A, Garc\u00eda-Garc\u00eda A, Chamorro-Petronacci C, L\u00f3pez-Jornet P, et al. Validity, reliability and optimisation of the TOPICOP questionnaire for oral lichen planus. Acta Odontol Scand. 2020;78(7):501\u20138.","journal-title":"Acta Odontol Scand"},{"issue":"1","key":"623_CR49","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.jaci.2006.02.031","volume":"118","author":"T Zuberbier","year":"2006","unstructured":"Zuberbier T, Orlow SJ, Paller AS, Ta\u00efeb A, Allen R, Hernanz-Hermosa JM, et al. Patient perspectives on the management of atopic dermatitis. J Allergy Clin Immunol. 2006;118(1):226\u201332.","journal-title":"J Allergy Clin Immunol"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-021-00623-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-021-00623-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-021-00623-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T05:51:41Z","timestamp":1635918701000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-021-00623-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,21]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["623"],"URL":"https:\/\/doi.org\/10.1007\/s40257-021-00623-6","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,21]]},"assertion":[{"value":"28 June 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No sources of funding were received for the preparation of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Marissa Contento, Abigail Cline, and Marian Russo have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Conceptualization: MC, AC; literature search: MC; drafting: MC, AC; critical revision: MC, AC, MR.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}